| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT01322191 |
| P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
| P17 | country | United States of America | Q30 |
| P582 | end time | 2010-11-01 | |
| P4135 | maximum age | 18 | |
| P2899 | minimum age | 3 | |
| P1132 | number of participants | 48 | |
| P4844 | research intervention | ketorolac tromethamine | Q27107089 |
| morphine | Q81225 | ||
| P6153 | research site | Children's Hospital of Michigan | Q5098127 |
| University of Utah Health Care | Q56582915 | ||
| P859 | sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development | Q5409765 |
| P580 | start time | 2008-04-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A Randomized Controlled Comparison of Ketorolac Tromethamine and Morphine for Postoperative Analgesia in Critically-ill, 3-18 Year-old Children: A Subgroup Analysis of Developmental Changes in Morphine Kinetics and Efficacy |
Search more.